Divozilimab (BCD-132) 是一种抗CD20(CD20) 的人源化单克隆抗体。Divozilimab 可用于多发性硬化症研究。
| 生物活性 | Divozilimab (BCD-132) is a humanised monoclonal antibody againstCD20(CD20). Divozilimab can be used for multiple sclerosis research[1]. |
| CAS 号 | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
